Choose your language
目錄下載(PDF)
Event Information
- 首頁
- 海報
- 議程概要
- 會前研討會講習 星期日
- 重點講演 星期一
- Oligonucleotide and Peptide Manufacturing Technology and Product Development
- Oligonucleotide Therapeutics Discovery
- Peptide Discovery and Development
- Nucleic Acids Technologies for Molecular Diagnostics
- 贊助商
- 展商
- 展覽Floor Plan(PDF)
- 夥伴
- 贊助商和展出的機會
- Interview with Art Krieg, M.D.
- 地點
- 詢問
- 報名註冊
產業會議彙總曆
TIDES: Oligonucleotide and Peptide® Research, Technology and Product Development
CSS
The Industry's Only Event for Full Coverage of the Oligonucleotide and Peptide Markets
2012年5月20-23日· Mandalay Bay Resort & Casino · Las Vegas, NV
議程概要
議程概要
- To view agenda details: Click the underlined links within the glance below (where applicable) to view the detailed agenda for that day, topic or course.
| 9:00 am - 1:00 pm | Course #1: Business and Operational Strategies for Successful Oligonucleotide Development | Course #2: Peptide Manufacturing and Analysis: A Basic Tutorial | Course #3: Early Drug Product Development | |
| 2:00 pm - 3:30 pm | Course #4: Peptide-Oligonucleotide Conjugation Strategies | Course #5: Oligonucleotide Lead Discovery and Optimization to Candidate Selection | ||
| 4:00 pm - 6:00 pm | Special Event: CMO-Sponsor Relationships in Therapeutic Development - Expectations and Realities (Open to all TIDES main conference attendees) |
|||
| 6:00 pm - 7:30 pm | Welcoming Reception for Course Attendees Co-Sponsored by: Avecia and IBC Life Sciences |
|||
| Poster and Exhibit Hall Hours: 3:15 pm - 7:15 pm | ||||
| 8:45 am - 12:30 pm |
|
|||
| 1:45 pm - 3:15 pm | Plenary Session | |||
| 3:15 pm | Opening of Poster and Exhibit Hall with Networking Refreshment Break | |||
| 3:55 pm - 6:00 pm | Plenary Session | |||
| 6:00 pm - 7:15 pm | Networking Reception in Poster and Exhibit Hall | |||
2012年5月22日, 星期二 Poster and Exhibit Hall Hours: 10:30 am - 6:30 pm | |||||||||||||||
| 寡核苷酸與肽的製造技術以及產品開發 | 寡核苷酸治療藥的創藥 | 肽創藥與開發 | 分子診斷用的核酸技術 | ||||||||||||
| Oligonucleotides | Peptides | ||||||||||||||
| 8:15 am - 10:30 am | CMC Challenges and Solutions Sponsored by Avecia |
Oligonucleotide Delivery: Mechanisms, Cellular Barriers and Cell/Tissue Targeting | Cell-Penetrating Peptides with Intrinsic Functional Activity: New Targets and Disease Mechanisms | Keynote Presentation: Regulatory Pathways and Quality Strategies |
|||||||||||
| 11:15 am - 12:45 pm | Strategy Discussion Forum: Quality by Design - Revisited Sponsored by Avecia |
Strategy Discussion Forum: When to Choose Recombinant vs. Synthetic Production of Peptides: The Complexities of a "Simple" Decision | Spotlight Presentations Sponsored by GE Healthcare, Peptisynth, and Sekisui | Oligonucleotide Delivery: Mechanisms, Cellular Barriers and Cell/Tissue Targeting | Innovations in Cell-Penetrating and Membrane-Permeating Peptides | ||||||||||
| 12:45 pm - 1:50 pm | Networking Luncheon in Poster and Exhibit Hall Sponsored by Lonza | ||||||||||||||
| 1:55 pm - 3:30 pm | CMC Challenges and Solutions Sponsored by Avecia |
CMC Challenges and Solutions Sponsored by Bachem |
New Data from Oligonucleotides in Development | Innovations in Cell-Penetrating and Membrane-Permeating Peptides | Peptide Generation, Lead Optimization and Candidate Selection Analytical Methods and Validation | ||||||||||
| 4:00 pm - 5:30 pm |
Strategy Discussion Forum: The Oligo Supply Chain: How Strong is the Weakest Link? Sponsored by Agilent Technologies Emerging Technologies Spotlight Presentations Sponsored by Agilent Technologies, BioSpring GmbH, and ST Pharma |
Emerging Technologies Spotlight Presentations Sponsored by Ajinomoto and Unigene Laboratories | |||||||||||||
| 5:30 pm - 6:30 pm | Networking Reception and Booth Crawl in Poster and Exhibit Hall with Dedicated Poster Viewing | ||||||||||||||
2012年5月23日, 星期三 Poster and Exhibit Hall Hours: 10:30 am - 2:00 pm | |||||||||||||||
| 寡核苷酸與肽的製造技術以及產品開發 | 寡核苷酸治療藥的創藥 | 肽創藥與開發 | 分子診斷用的核酸技術 | ||||||||||||
| Oligonucleotides | Peptides | ||||||||||||||
| 8:25 am - 10:30 am | Early Drug Product Development for Oligos and Peptides | Preclinical Chemical Modifications to Improve Drug-Like Properties | Novel Peptide-Like Scaffolds and Peptide Discovery |
Keynote Presentation: The Next Generation in Clinical Molecular Diagnostics Manufacturing and Business Considerations for Successful Launch in Clinical Market |
|||||||||||
| 11:15 am - 12:45 pm |
Strategy Discussion Forum: Impurities: At What Stage do you Need to Qualify Impurities Strategy Discussion Forum: Preclinical Evaluation of Immunomodulatory Effects of Oligonucleotides and Formulations: Challenges and Strategies |
Strategy Discussion Forum: Strategies for Formulation Transition | Emerging Preclinical and Clinical Results | New Approaches to Making Drug-Like Peptides | |||||||||||
| 12:45 pm - 1:55 pm | Networking Luncheon, Exhibit and Poster Viewing in Exhibit Hall | ||||||||||||||
| 1:50 pm - 3:30 pm | CMC Aspects of Alternative Delivery Routes | CMC Aspects of Alternative Delivery Routes | Emerging Preclinical and Clinical Results |
New Approaches to Making Drug-Like Peptides Creative Strategies to Improve Peptide Drug Discovery and Expand Target Space |
New Technologies | ||||||||||
| 4:00 pm - 5:30 pm | Strategy Discussion Forum: Alternative Delivery Platforms for Oligonucleotide and Peptide Therapeutics | Strategy Discussion Forum: Conjugation: From a One-Off Approach to a Platform Technology - Pros and Cons | |||||||||||||
| 5:30 pm | Close of Conference | ||||||||||||||